As telehealth grows and becomes more mainstream, all kinds of questions often arise.  They range from administrative to operational to legal issues. In conjunction with the American Hospital Association, my colleague Amy Lerman and I have co-written two white papers for the American Hospital Association Trendwatch series focusing on telehealth issues. Among other things,

On November 13, 2014, the Health Resources and Services Administration (“HRSA”) announced its plans to abandon the much anticipated “mega-reg” amid questions concerning HRSA’s rule-making authority.  The “mega-reg” was expected to provide much needed clarity to the 340B drug discount program (the “340B Program”) by addressing, among other things, the definition of an eligible patient,